References
[1]Carroll JL. Obstructive sleep-disordered breathing in children: new controversies, new directions[J]. Clin Chest Med, 2003, 24(2):261-282.
[2]刘玺诚,卢秀英,崔振泽.全国8城市2-12岁儿童睡眠状况流行病学调查[J]. 睡眠医学,2004,1(1):4-7.
[3]Guilleminault C, Korobkin R, Winkle R. A review of 50 children with obstructive sleep apnea syndrome[J]. Lung, 1981, 159(5):275-287.
[4]Leung LC, Ng DK, Lau MW, Chan CH, Kwok KL, Chow PY, et al. Twenty-four-hour ambulatory BP in snoring children with obstructive sleep apnea syndrome[J]. Chest, 2006, 130(4):1009-1017.
[5]Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death[J]. N Engl J Med, 2005, 353(19):2034-2041.
[6]Javaheri S, Parker TJ, Liming JD. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations[J]. Circulation, 1998, 97(21): 2154-2159.
[7]Capdevila OS, Kheirandish-Gozal L, Dayyat E, Gozal D. Pediatric obstructive sleep apnea: complications, management, and long-term outcomes[J]. Proc Am Thorac Soc, 2008, 5(2):274-282.
[8]Katz ES, D′Ambrosio CM. Pathophysiology of pediatric obstructive sleep apnea[J]. Proc Am Thorac Soc, 2008, 5(2): 253-262.
[9]Tharaux PL. Effect of sleep apnea syndrome on the vascular endothelium[J]. Rev Neurol (Paris), 2003,159(11 Suppl):6S102-6S106.
[10]Lavie L. Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities[J]. Prog Cardiovasc Dis, 2009, 51(4):303-312.
[11]Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, et al. Elevated C-reactive protein in patients with obstructive sleep apnea[J]. Circulation,2002,105(21):2462-2464.
[12]Ishida K, Kato M, Kato Y, Yanagihara K, Kinugasa Y, Kotani K. Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea[J]. Chest, 2009, 136(1):125-129.
[13]Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdotlir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease[J]. N Engl J Med, 2004, 350(14):1387-1397.
[14]沈立松. 急性时相蛋白C-反应蛋白的临床意义[J].临床儿科杂志, 2003,21(4): 253-256.
[15]Larkin EK, Rosen CL, Kirchner HL, Storfer-lsser A, Emancipator JL, Johnson NL, et al. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration[J]. Circulation, 2005, 111(15):1978-1984.
[16]Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells[J]. Circulation, 2002,106(12):1439-1441.
[17]O′Brien LM, Serpero LD, Tauman R, Gozal D. Plasma adhesion molecules in children with sleep-disordered breathing[J]. Chest, 2006, 129(4): 947-953.
[18]Kokturk O, Ciftci TU, Mollarecep E, Ciftci B. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome[J]. Int Heart J, 2005, 46(5):801-809.
[19]Gozal D, Crabtree VM, Sans Capdevila O, Witcher LA, Kheirandish-Gozal L. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children[J]. Am J Respir Crit Care Med, 2007, 176(2): 188-193.
[20]Li AM, Chan MH, Yin J, So HK, Ng SK, Chan IM, et al. C-reactive protein in children with obstructive sleep apnea and the effects of treatment[J]. Pediatr Pulmonol, 2008, 43(1): 34-40.
[21]Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea[J].Chest, 2004, 125(1):112-117.
[22]Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type Ⅱ diabetes: a populationbased study[J]. Am J Respir Crit Care Med, 2005, 172(12):1590-1595.
[23]Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K, Dhingra V, et al. Association between subclinical inflammation & fasting insulin in urban young adult north Indian males[J].Indian J Med Res, 2006, 124(6): 677-682.